1. Iron absorption in adults with sickle cell anemia: a stable-isotope approach.
- Author
-
Omena¹, Juliana, Bezerra¹, Flávia Fioruci, Voll¹, Vanessa Monteiro, Braz, Bernardo Ferreira, Santelli, Ricardo Erthal, Donangelo, Carmen Marino, Jauregui, Gustavo Federico, Ribeiro, Andrea Soares, dos Santos Cople Rodrigues, Cláudia, and Citelli, Marta
- Subjects
- *
IRON metabolism , *IRON analysis , *LIVER analysis , *IRON , *IRON in the body , *SICKLE cell anemia , *IRON regulatory proteins , *RESEARCH funding , *FERRITIN , *PILOT projects , *IRON overload , *MASS spectrometry , *ISOTOPES , *BIOAVAILABILITY , *MEMBRANE proteins - Abstract
Purpose: Iron absorption in sickle cell anemia (SCA) remains unclear and studies in adults with SCA are scarce. The aim of this study was to evaluate the iron absorption SCA adults and its association with iron status and hepcidin concentration. Methods: SCA patients (n = 13; SCAtotal) and control participants (n = 10) ingested an oral stable iron isotope (57Fe). Iron absorption was measured by inductively coupled plasma mass spectrometry (ICP-MS) 14 days after isotope administration. Patients with ≥ 1000 ng/mL serum ferritin were considered to present iron overload (IO) (SCAio+; n = 3) and others classified without IO (SCAio-; n = 10). Results: Iron absorption in the control group ranged from 0.3 to 26.5% (median = 0.9%), while it varied from 0.3 to 5.4% in SCAio+ (median = 0.5%) and from 0.3 to 64.2% in the SCAio- (median = 6.9%). Hepcidin median values were 14.1 ng/mL (3.0–31.9 ng/mL) in SCAio-, 6.2 ng/mL (3.3–7.8 ng/mL) in SCAio + and 6.2 ng/mL (0.6–9.3 ng/mL) in control. Iron absorption was associated with ferritin level (r = − 0.641; p = 0.018) and liver iron concentration (LIC; r = − 0.786; p = 0.036) in the SCAtotal group. Conclusion: Our data suggest that SCAio- individuals may be at risk of developing primary IO. Simultaneously, secondary IO may induce physiological adaptation, resulting in reduced iron absorption. Further studies evaluating intestinal iron absorption using larger sample sizes should be conducted to help establish a safe nutrition approach to be adopted and to ensure the security of food-fortifying public policies for these patients. Trial registration: This trial was registered at www.ensaiosclinicos.gov.br (Identifier RBR-4b7v8pt). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF